Gregory Demopulos
Directeur Général chez OMEROS CORPORATION
Fortune : 6 M $ au 30/04/2024
Postes actifs de Gregory Demopulos
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OMEROS CORPORATION | Directeur Général | 16/06/1994 | - |
| Président | 16/06/1994 | - | |
| Fondateur | 05/10/2009 | - | |
| President | 16/06/1994 | - | |
| Directeur Technique/Scientifique/R&D | 16/06/1994 | 03/05/2010 | |
| Directeur Financier/CFO | 03/05/2010 | 17/10/2013 | |
| Treasurer | 03/05/2010 | 19/06/2014 | |
Tessera, Inc.
 Tessera, Inc. SemiconductorsElectronic Technology Tessera, Inc. provides packaging solutions for the semiconductor industry. The company was founded on December 16, 1992 and is headquartered in San Jose, CA. | Directeur/Membre du Conseil | - | - |
Onconome, Inc.
 Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | - | - |
| Smead Funds Trust | Directeur/Membre du Conseil | - | - |
| Northwest NeuroNeighborhood | Directeur/Membre du Conseil | - | - |
Historique de carrière de Gregory Demopulos
Formation de Gregory Demopulos
| Stanford University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Director/Board Member | 4 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| Entreprise privées | 4 |
|---|---|
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | Health Technology |
| Smead Funds Trust | Miscellaneous |
Tessera, Inc.
Tessera, Inc. SemiconductorsElectronic Technology Tessera, Inc. provides packaging solutions for the semiconductor industry. The company was founded on December 16, 1992 and is headquartered in San Jose, CA. | Electronic Technology |
| Northwest NeuroNeighborhood |
- Bourse
- Insiders
- Gregory Demopulos
- Expérience
